Balaxi Pharma (BALAXI)
STALWARTScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹27.5 |
| Market Cap | ₹108.92 Cr |
| P/E Ratio | 11.53 |
| ROCE | 12.95% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -94.22% |
| Debt/Equity | 0.24 |
| Sales Growth | -1.02% |
| Promoter Holding | 65.99% |
| 52-Week Range | ₹15.2 — ₹55.64 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹45.56 |
Balaxi Pharma trades with a P/E ratio of 11.53, ROCE of 12.95%, profit growth of -94.22%, debt-to-equity of 0.24.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer